CPA
TWST icon

Capital Performance Advisors’s Twist Bioscience TWST Stock Holding History

Capital Performance Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-150
Closed -$6.78K – 2513
2024
Q3 		$6.78K Buy
+150
New +$7.14K ﹤0.01% 982

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Performance Advisors's TWST Position: Q4 2024 in Review

Capital Performance Advisors sold out of Twist Bioscience (TWST) in Q4 2024, closing a stake of 150 shares — an estimated $6.78K sold.

Capital Performance Advisors first reported a position in TWST in Q3 2024 and held it in 1 quarter. The position peaked at $6.78K in Q3 2024. 246 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

  • Capital Performance Advisors reported no remaining Twist Bioscience position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 150 Twist Bioscience shares in Q4 2024, an estimated $6.78K.
  • Capital Performance Advisors first reported a position in Twist Bioscience in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Twist Bioscience position peaked at $6.78K in Q3 2024.
  • 246 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.